Terms: = Lung cancer AND CREB3L1, 90993, Q96BA8, OASIS, ENSG00000157613
19 results:
1. Network pharmacology study to explore the multiple molecular mechanism of SH003 in the treatment of non-small cell lung cancer.
Lee K; Choi YJ; Lim HI; Cho KJ; Kang N; Ko SG
BMC Complement Med Ther; 2024 Feb; 24(1):70. PubMed ID: 38303001
[TBL] [Abstract] [Full Text] [Related]
2. Outcome prediction for critical care patients with respiratory neoplasms using a multilayer perceptron neural network.
Nistal-Nuño B
Einstein (Sao Paulo); 2023; 21():eAO0071. PubMed ID: 37729310
[TBL] [Abstract] [Full Text] [Related]
3. The Optimizing lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing lung Screening.
Foley KL; Dressler EV; Weaver KE; Sutfin EL; Miller DP; Bellinger C; Kittel C; Stone RJ; Petty WJ; Land SR; Spangler JG; Lesser GJ; Chiles C;
Chest; 2023 Aug; 164(2):531-543. PubMed ID: 36931460
[TBL] [Abstract] [Full Text] [Related]
4. Machine learning for prediction of in-hospital mortality in lung cancer patients admitted to intensive care unit.
Huang T; Le D; Yuan L; Xu S; Peng X
PLoS One; 2023; 18(1):e0280606. PubMed ID: 36701342
[TBL] [Abstract] [Full Text] [Related]
5. Automated Optimized Synthesis of [
Fedorova OS; Orlovskaya VV; Krasikova RN
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500417
[TBL] [Abstract] [Full Text] [Related]
6. Reduced creb3l1 expression in triple negative and luminal a breast cancer cells contributes to enhanced cell migration, anchorage-independent growth and metastasis.
Mellor P; Kendall S; Smith S; Saxena A; Anderson DH
PLoS One; 2022; 17(7):e0271090. PubMed ID: 35802566
[TBL] [Abstract] [Full Text] [Related]
7. Metastatic pediatric sclerosing epithelioid fibrosarcoma.
Woods AD; Purohit R; Mitchell LC; Collier JR; Collier KA; Lathara M; Learned K; Vaske O; Geiger H; Wrzeszczynski KO; Jobanputra V; Srinivasa G; Rudzinski ER; Whelan K; Beierle E; Spunt SL; Keller C; Wadhwa A
Cold Spring Harb Mol Case Stud; 2021 Oct; 7(5):. PubMed ID: 34362827
[TBL] [Abstract] [Full Text] [Related]
8. Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.
Warmke LM; Meis JM
Am J Surg Pathol; 2021 Mar; 45(3):317-328. PubMed ID: 32769431
[TBL] [Abstract] [Full Text] [Related]
9. Sclerosing epithelioid fibrosarcoma: cytologic characterization with histologic, immunohistologic, molecular, and clinical correlation of 8 cases.
Porteus C; Gan Q; Gong Y; Pantanowitz L; Henderson-Jackson E; Saeed-Vafa D; Mela N; Peterson D; Ahmad N; Ahmed A; Bui M
J Am Soc Cytopathol; 2020; 9(6):513-519. PubMed ID: 32624384
[TBL] [Abstract] [Full Text] [Related]
10. An
Bissonnette C; Shilo K; Liebner D; Rogers A; Pollock RE; Iwenofu OH
Int J Surg Pathol; 2021 Feb; 29(1):109-116. PubMed ID: 32506986
[TBL] [Abstract] [Full Text] [Related]
11. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
Dora D; Rivard C; Yu H; Bunn P; Suda K; Ren S; Lueke Pickard S; Laszlo V; Harko T; Megyesfalvi Z; Moldvay J; Hirsch FR; Dome B; Lohinai Z
Mol Oncol; 2020 Sep; 14(9):1947-1965. PubMed ID: 32506804
[TBL] [Abstract] [Full Text] [Related]
12. The oasis trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer.
Foley KL; Miller DP; Weaver K; Sutfin EL; Petty WJ; Bellinger C; Spangler J; Stone RJ; Lawler D; Davis W; Dressler E; Lesser G; Chiles C
Contemp Clin Trials; 2020 Apr; 91():105963. PubMed ID: 32087340
[TBL] [Abstract] [Full Text] [Related]
13. Herbal medicine on cancer-related fatigue of lung cancer survivors: Protocol for a systematic review.
Kwon CY; Lee B; Kim KI; Lee BJ
Medicine (Baltimore); 2020 Jan; 99(5):e18968. PubMed ID: 32000424
[TBL] [Abstract] [Full Text] [Related]
14. creb3l1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy.
Denard B; Jiang S; Peng Y; Ye J
BMC Cancer; 2018 Aug; 18(1):813. PubMed ID: 30103710
[TBL] [Abstract] [Full Text] [Related]
15. Opportunistic autoimmunity secondary to cancer immunotherapy (OASI): An emerging challenge.
Kostine M; Chiche L; Lazaro E; Halfon P; Charpin C; Arniaud D; Retornaz F; Blanco P; Jourde-Chiche N; Richez C; Stavris C
Rev Med Interne; 2017 Aug; 38(8):513-525. PubMed ID: 28214182
[TBL] [Abstract] [Full Text] [Related]
16. A traditional herbal medication, Maekmoondong-tang, for cough: A systematic review and meta-analysis.
Kim KI; Shin S; Lee N; Lee BJ; Lee J; Lee H
J Ethnopharmacol; 2016 Feb; 178():144-54. PubMed ID: 26666732
[TBL] [Abstract] [Full Text] [Related]
17. The development of a standardized software platform to support provincial population-based cancer outcomes units for multiple tumour sites: oasis - Outcomes and Surveillance Integration System.
Wu J; Ho C; Laskin J; Gavin D; Mak P; Duncan K; French J; McGahan C; Reid S; Chia S; Cheung H
Stud Health Technol Inform; 2013; 183():98-103. PubMed ID: 23388263
[TBL] [Abstract] [Full Text] [Related]
18. Development of a robust LC-MS/MS method for determination of desmosine and isodesmosine in human urine.
Shiraishi K; Matsuzaki K; Matsumoto A; Hashimoto Y; Iba K
J Oleo Sci; 2010; 59(8):431-9. PubMed ID: 20625235
[TBL] [Abstract] [Full Text] [Related]
19. Quantification of F(2)-isoprostane isomers in cultured human lung epithelial cells after silica oxide and metal oxide nanoparticle treatment by liquid chromatography/tandem mass spectrometry.
Liu X; Whitefield PD; Ma Y
Talanta; 2010 Jun; 81(4-5):1599-606. PubMed ID: 20441945
[TBL] [Abstract] [Full Text] [Related]
